Accumulation of avirulent Bordetella pertussis Bvg mutants in the course of experimental whooping cough in mice

被引:2
|
作者
Medkova, A. Yu [1 ]
Sinyashina, L. N. [1 ]
Rumyantseva, Yu P. [1 ]
Voronina, O. L. [1 ]
Kunda, M. S. [1 ]
Karataev, G. I. [1 ]
机构
[1] Minist Hlth Russian Federat, Gamaleya Sci Res Inst Epidemiol & Microbiol, Moscow 123098, Russia
关键词
causative agent of whooping cough; persistence; insertional mutants; virulence; EPIDEMIOLOGY;
D O I
10.3103/S0891416813040058
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The duration and dynamics of accumulation of insertional Bordetella pertussis Bvg(-) mutants were studied in the lungs of laboratory mice after intranasal and intravenous challenge by virulent bacteria of the causative agent of whooping cough. The ability of the virulent B. pertussis bacteria to remain for a long time in the body of mice was established. Using real-time PCR, a hundred genome equivalents of DNA of B. pertussis were detected in lungs of mice 2 months after infection regardless of type of challenge. Using the bacterial test bacteria were identified during only 4 weeks after challenge. Avirulent Bordetella pertussis Bvg(-) mutants were accumulated in the period of infection. The percentage of the avirulent bacteria in the B. pertussis population reached 50% in 7-9 weeks after challenge. The obtained results show that laboratory mice can be used to study the dynamics of accumulation of B. pertussis insertion mutants in vivo and confirm the hypothesis that there is accumulation of insertion avirulent Bordetella pertussis Bvg(-) mutants during development of pertussis infection in human.
引用
收藏
页码:156 / 161
页数:6
相关论文
共 50 条
  • [41] Binding of murine antibodies against whole-cell pertussis vaccine or filamentous haemagglutinin by Bordetella pertussis from patients with whooping cough
    van den Berg, BM
    Beekhuizen, H
    Van Furth, R
    Mooi, FR
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2000, 51 (05) : 530 - 532
  • [42] A Subtraction Genomics-Based Approach to Identify and Characterize New Drug Targets in Bordetella pertussis: Whooping Cough
    Jamal, Alam
    Jahan, Sadaf
    Choudhry, Hani
    Rather, Irfan A.
    Khan, Mohammad Imran
    VACCINES, 2022, 10 (11)
  • [43] BORDETELLA-PERTUSSIS AND UPPER RESPIRATORY-TRACT INFECTION VIRUSES IN EGYPTIAN CHILDREN WITH WHOOPING-COUGH
    FATHALLA, SE
    NAMNYAK, SS
    KING FAISAL SPECIALIST HOSPITAL MEDICAL JOURNAL, 1984, 4 (04): : 295 - 299
  • [44] Comparative genomics of Bordetella pertussis isolates from New Zealand, a country with an uncommonly high incidence of whooping cough
    Ring, Natalie
    Davies, Heather
    Morgan, Julie
    Sundaresan, Maithreyi
    Tiong, Audrey
    Preston, Andrew
    Bagby, Stefan
    MICROBIAL GENOMICS, 2022, 8 (01):
  • [45] PCR testing for Bordetella pertussis in household contacts as a diagnostic tool for atypical whooping cough in unvaccinated young infants
    Cosnes-Lambe, Cecile
    Raymond, Josette
    Vallet, Christelle
    Armengaud, Jean-Baptiste
    Bosdure, Emmanuelle
    Catalano-Pons, Charlotte
    Chalumeau, Martin
    El Hajje, Marie-Joelle
    Moulin, Florence
    de Suremain, Nathalie
    Reglier-Poupet, Helene
    Poyart, Claire
    Gendrel, Dominique
    PRESSE MEDICALE, 2008, 37 (10): : 1371 - 1376
  • [46] SPECIFIC IMMUNOGLOBULIN-A TO BORDETELLA-PERTUSSIS ANTIGENS IN MUCOSAL SECRETION FOR RAPID DIAGNOSIS OF WHOOPING-COUGH
    GRANSTROM, G
    ASKELOF, P
    GRANSTROM, M
    JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (05) : 869 - 874
  • [47] CHARACTERIZATION OF GENETICALLY INACTIVATED PERTUSSIS TOXIN MUTANTS - CANDIDATES FOR A NEW VACCINE AGAINST WHOOPING-COUGH
    NENCIONI, L
    PIZZA, M
    BUGNOLI, M
    DEMAGISTRIS, T
    DITOMMASO, A
    GIOVANNONI, F
    MANETTI, R
    MARSILI, I
    MATTEUCCI, G
    NUCCI, D
    OLIVIERI, R
    PILERI, P
    PRESENTINI, R
    VILLA, L
    KREEFTENBERG, JG
    SILVESTRI, S
    TAGLIABUE, A
    RAPPUOLI, R
    INFECTION AND IMMUNITY, 1990, 58 (05) : 1308 - 1315
  • [50] Neither the Bvg- phase nor the vrg6 locus of Bordetella pertussis is required for respiratory infection in mice
    de Tejada, GM
    Cotter, PA
    Heininger, U
    Camilli, A
    Akerley, BJ
    Mekalanos, JJ
    Miller, JF
    INFECTION AND IMMUNITY, 1998, 66 (06) : 2762 - 2768